Femarelle drug treats menopause onset osteoporosis sans hormones
The connection between menopause and osteoporosis is well-documented. At the onset of menopause, following the decrease of estrogen in the body, the bone undergoes a yearly decline of bone mass density (BMD) of 2 percent to 3 percent a year in the first seven years following menopause. This leads to the development of osteoporosis, which affects 50 percent of postmenopausal women today.